Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues

J Virol. 1999 Feb;73(2):1729-33. doi: 10.1128/JVI.73.2.1729-1733.1999.

Abstract

Many mucosal pathogens invade the host by initially infecting the organized mucosa-associated lymphoid tissue (o-MALT) such as Peyer's patches or nasal cavity-associated lymphoid tissue (NALT) before spreading systemically. There is no clear demonstration that serum antibodies can prevent infections in o-MALT. We have tested this possibility by using the mouse mammary tumor virus (MMTV) as a model system. In peripheral lymph nodes or in Peyer's patches or NALT, MMTV initially infects B lymphocytes, which as a consequence express a superantigen (SAg) activity. The SAg molecule induces the local activation of a subset of T cells within 6 days after MMTV infection. We report that similar levels of anti-SAg antibody (immunoglobulin G) in serum were potent inhibitors of the SAg-induced T-cell response both in peripheral lymph nodes and in Peyer's patches or NALT. This result clearly demonstrates that systemic antibodies can gain access to Peyer's patches or NALT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / immunology*
  • Antigens, Viral / immunology*
  • Immunity, Mucosal
  • Immunoglobulin G / immunology
  • Lymphoid Tissue / immunology
  • Mammary Tumor Virus, Mouse / immunology*
  • Mice
  • Mucous Membrane / immunology
  • Superantigens / immunology*

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Immunoglobulin G
  • Superantigens